Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash & Current Investments (2016 - 2020)

Historic Cash & Current Investments for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $20.2 million.

  • Forte Biosciences' Cash & Current Investments fell 2103.21% to $20.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $20.2 million, marking a year-over-year decrease of 2103.21%. This contributed to the annual value of $6.9 million for FY2019, which is 8299.81% down from last year.
  • As of Q3 2020, Forte Biosciences' Cash & Current Investments stood at $20.2 million, which was down 2103.21% from $27.7 million recorded in Q2 2020.
  • Forte Biosciences' 5-year Cash & Current Investments high stood at $76.1 million for Q2 2017, and its period low was $4.1 million during Q3 2016.
  • Moreover, its 5-year median value for Cash & Current Investments was $20.2 million (2020), whereas its average is $24.5 million.
  • Per our database at Business Quant, Forte Biosciences' Cash & Current Investments soared by 173077.3% in 2017 and then plummeted by 8299.81% in 2019.
  • Quarter analysis of 5 years shows Forte Biosciences' Cash & Current Investments stood at $5.5 million in 2016, then soared by 552.14% to $35.9 million in 2017, then grew by 13.58% to $40.8 million in 2018, then crashed by 83.0% to $6.9 million in 2019, then surged by 191.11% to $20.2 million in 2020.
  • Its Cash & Current Investments was $20.2 million in Q3 2020, compared to $27.7 million in Q2 2020 and $14.2 million in Q1 2020.